Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.

Bauman JE, Duvvuri U, Thomas S, Gooding WE, Clump DA, Karlovits B, Wehbe A, Miller FR, Kim S, Sen M, Heron DE, Grandis JR, Argiris A.

Cancer. 2018 Oct 1;124(19):3881-3889. doi: 10.1002/cncr.31651. Epub 2018 Oct 6.

PMID:
30291796
2.

Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty.

Medina EA, Fuehrer NE, Miller FR, Kinney MC, Higgins RA.

Pathol Int. 2016 Sep;66(9):535-9. doi: 10.1111/pin.12446.

PMID:
27593552
3.

'Cytology-on-a-chip' based sensors for monitoring of potentially malignant oral lesions.

Abram TJ, Floriano PN, Christodoulides N, James R, Kerr AR, Thornhill MH, Redding SW, Vigneswaran N, Speight PM, Vick J, Murdoch C, Freeman C, Hegarty AM, D'Apice K, Phelan JA, Corby PM, Khouly I, Bouquot J, Demian NM, Weinstock YE, Rowan S, Yeh CK, McGuff HS, Miller FR, Gaur S, Karthikeyan K, Taylor L, Le C, Nguyen M, Talavera H, Raja R, Wong J, McDevitt JT.

Oral Oncol. 2016 Sep;60:103-11. doi: 10.1016/j.oraloncology.2016.07.002. Epub 2016 Jul 20.

4.

Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials.

Speight PM, Abram TJ, Floriano PN, James R, Vick J, Thornhill MH, Murdoch C, Freeman C, Hegarty AM, D'Apice K, Kerr AR, Phelan J, Corby P, Khouly I, Vigneswaran N, Bouquot J, Demian NM, Weinstock YE, Redding SW, Rowan S, Yeh CK, McGuff HS, Miller FR, McDevitt JT.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Oct;120(4):474-82.e2. doi: 10.1016/j.oooo.2015.05.023. Epub 2015 Jun 17.

5.

Allelic variants in the PRR37 gene and the human-mediated dispersal and diversification of sorghum.

Klein RR, Miller FR, Dugas DV, Brown PJ, Burrell AM, Klein PE.

Theor Appl Genet. 2015 Sep;128(9):1669-83. doi: 10.1007/s00122-015-2523-z. Epub 2015 May 16.

PMID:
25982128
6.

PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.

Meng F, Speyer CL, Zhang B, Zhao Y, Chen W, Gorski DH, Miller FR, Wu G.

Cancer Res. 2015 Feb 1;75(3):584-93. doi: 10.1158/0008-5472.CAN-13-3029. Epub 2014 Dec 10.

7.

Prevalence of HPV associated oropharyngeal cancer among south Texans.

Rowan SD, DiBurro M, Westbrook S, Redding SW, Miller FR.

Tex Dent J. 2014 May;131(5):376-81.

PMID:
25115130
8.

Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma.

Tantiwongkosi B, Yu F, Kanard A, Miller FR.

World J Radiol. 2014 May 28;6(5):177-91. doi: 10.4329/wjr.v6.i5.177. Review.

9.

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.

Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres Torres KE, Barnard NJ, Kim HJ, Sloane BF, Miller FR, Goydos JS, Gorski DH.

PLoS One. 2014 Jan 3;9(1):e81126. doi: 10.1371/journal.pone.0081126. eCollection 2014.

10.

Hemangiopericytoma of the parapharyngeal space.

Fishero BA, Guido KM, McGuff HS, Heim-Hall JM, Miller FR.

Ear Nose Throat J. 2013 Sep;92(9):436-40.

PMID:
24057903
11.

Review of accessory parotid gland tumors: pathologic incidence and surgical management.

Newberry TR, Kaufmann CR, Miller FR.

Am J Otolaryngol. 2014 Jan-Feb;35(1):48-52. doi: 10.1016/j.amjoto.2013.08.018. Epub 2013 Sep 16.

PMID:
24051232
12.

The role of nerve monitoring to predict postoperative recurrent laryngeal nerve function in thyroid and parathyroid surgery.

Eid I, Miller FR, Rowan S, Otto RA.

Laryngoscope. 2013 Oct;123(10):2583-6. doi: 10.1002/lary.23946. Epub 2013 Aug 5.

PMID:
23918194
13.

Intraoperative relationship of the spinal accessory nerve to the internal jugular vein: variation from cadaver studies.

Taylor CB, Boone JL, Schmalbach CE, Miller FR.

Am J Otolaryngol. 2013 Sep-Oct;34(5):527-9. doi: 10.1016/j.amjoto.2013.05.008. Epub 2013 Jun 28.

PMID:
23810370
14.

Hypopharyngeal diverticulum after cervical spine surgery; the role of endoscopic management.

Rippentropp SM, Miller FR.

Am J Otolaryngol. 2013 May-Jun;34(3):216-8. doi: 10.1016/j.amjoto.2012.12.001. Epub 2013 Jan 11.

PMID:
23313121
15.

Coincident light and clock regulation of pseudoresponse regulator protein 37 (PRR37) controls photoperiodic flowering in sorghum.

Murphy RL, Klein RR, Morishige DT, Brady JA, Rooney WL, Miller FR, Dugas DV, Klein PE, Mullet JE.

Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16469-74. doi: 10.1073/pnas.1106212108. Epub 2011 Sep 19.

16.

Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis.

Puliyappadamba VT, Wu W, Bevis D, Zhang L, Polin L, Kilkuskie R, Finley RL Jr, Larsen SD, Levi E, Miller FR, Wali A, Rishi AK.

J Biol Chem. 2011 Nov 4;286(44):38000-17. doi: 10.1074/jbc.M111.222398. Epub 2011 Sep 8.

17.

Management of lateral cervical metastases in papillary thyroid cancer: patterns of lymph node distribution.

King JM, Corbitt C, Miller FR.

Ear Nose Throat J. 2011 Aug;90(8):386-9.

PMID:
21853444
18.

Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.

Zhang H, Meng F, Wu S, Kreike B, Sethi S, Chen W, Miller FR, Wu G.

Cancer Res. 2011 Jul 15;71(14):4846-56. doi: 10.1158/0008-5472.CAN-11-0414. Epub 2011 Jul 12.

19.
20.

Predicting hypocalcemia after total thyroidectomy: parathyroid hormone level vs. serial calcium levels.

Graff AT, Miller FR, Roehm CE, Prihoda TJ.

Ear Nose Throat J. 2010 Sep;89(9):462-5.

PMID:
20859873
21.

Nano-bio-chip sensor platform for examination of oral exfoliative cytology.

Weigum SE, Floriano PN, Redding SW, Yeh CK, Westbrook SD, McGuff HS, Lin A, Miller FR, Villarreal F, Rowan SD, Vigneswaran N, Williams MD, McDevitt JT.

Cancer Prev Res (Phila). 2010 Apr;3(4):518-28. doi: 10.1158/1940-6207.CAPR-09-0139. Epub 2010 Mar 23.

22.

Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model.

Wang SX, Bao A, Phillips WT, Goins B, Herrera SJ, Santoyo C, Miller FR, Otto RA.

Int J Pharm. 2009 May 21;373(1-2):156-64. doi: 10.1016/j.ijpharm.2009.02.009. Epub 2009 Feb 21.

PMID:
19429301
23.

Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.

Fu J, Weise AM, Falany JL, Falany CN, Thibodeau BJ, Miller FR, Kocarek TA, Runge-Morris M.

Breast Cancer Res Treat. 2010 Feb;120(1):35-45. doi: 10.1007/s10549-009-0363-8. Epub 2009 Mar 24.

24.

Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression.

Kim SH, Miller FR, Tait L, Zheng J, Novak RF.

Int J Cancer. 2009 Jun 15;124(12):2813-28. doi: 10.1002/ijc.24278.

25.
26.

Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.

Ye CJ, Stevens JB, Liu G, Bremer SW, Jaiswal AS, Ye KJ, Lin MF, Lawrenson L, Lancaster WD, Kurkinen M, Liao JD, Gairola CG, Shekhar MP, Narayan S, Miller FR, Heng HH.

J Cell Physiol. 2009 May;219(2):288-300. doi: 10.1002/jcp.21663.

27.

Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.

Shekhar MP, Tait L, Pauley RJ, Wu GS, Santner SJ, Nangia-Makker P, Shekhar V, Nassar H, Visscher DW, Heppner GH, Miller FR.

Cancer Biol Ther. 2008 Nov;7(11):1774-82. Epub 2008 Nov 12.

28.

Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach.

Wang Y, Ao X, Vuong H, Konanur M, Miller FR, Goodison S, Lubman DM.

J Proteome Res. 2008 Oct;7(10):4313-25. doi: 10.1021/pr8002547. Epub 2008 Aug 27.

29.

Intraoperative 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model.

Wang SX, Bao A, Herrera SJ, Phillips WT, Goins B, Santoyo C, Miller FR, Otto RA.

Clin Cancer Res. 2008 Jun 15;14(12):3975-83. doi: 10.1158/1078-0432.CCR-07-4149.

30.

Differential expression of acidic proteins with progression in the MCF10 model of human breast disease.

Buchanan NS, Zhao J, Zhu K, Patwa TH, Miller FR, Lubman DM.

Int J Oncol. 2007 Oct;31(4):941-9.

PMID:
17786328
31.

Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.

Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA.

Head Neck. 2008 Jan;30(1):28-34.

PMID:
17657782
32.

Accuracy of cone beam computed tomography in determining the location of the genial tubercle.

Hueman EM, Noujeim ME, Langlais RP, Prihoda TJ, Miller FR.

Otolaryngol Head Neck Surg. 2007 Jul;137(1):115-8.

PMID:
17599577
33.

Occult primary head and neck carcinoma.

Schmalbach CE, Miller FR.

Curr Oncol Rep. 2007 Mar;9(2):139-46. Review.

PMID:
17288881
34.

Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.

Tait LR, Pauley RJ, Santner SJ, Heppner GH, Heng HH, Rak JW, Miller FR.

Int J Cancer. 2007 May 15;120(10):2127-34.

35.

Comprehensive analysis of proteins of pH fractionated samples using monolithic LC/MS/MS, intact MW measurement and MALDI-QIT-TOF MS.

Yoo C, Patwa TH, Kreunin P, Miller FR, Huber CG, Nesvizhskii AI, Lubman DM.

J Mass Spectrom. 2007 Mar;42(3):312-34.

36.

Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats.

Bao A, Phillips WT, Goins B, McGuff HS, Zheng X, Woolley FR, Natarajan M, Santoyo C, Miller FR, Otto RA.

Otolaryngol Head Neck Surg. 2006 Dec;135(6):853-7.

PMID:
17141073
37.

The endoscopic management of Zenker diverticulum: CO2 laser versus endoscopic stapling.

Miller FR, Bartley J, Otto RA.

Laryngoscope. 2006 Sep;116(9):1608-11.

PMID:
16954989
38.
39.

Proteomic analysis of estrogen response of premalignant human breast cells using a 2-D liquid separation/mass mapping technique.

Zhao J, Zhu K, Lubman DM, Miller FR, Shekhar MP, Gerard B, Barder TJ.

Proteomics. 2006 Jul;6(13):3847-61.

40.

The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.

Brkovich VS, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA.

Laryngoscope. 2006 Jun;116(6):855-8.

PMID:
16735902
41.

Toward high sequence coverage of proteins in human breast cancer cells using on-line monolith-based HPLC-ESI-TOF MS compared to CE MS.

Yoo C, Pal M, Miller FR, Barder TJ, Huber C, Lubman DM.

Electrophoresis. 2006 Jun;27(11):2126-38.

42.

Risk factors for the development of hypothyroidism after hemithyroidectomy.

Miller FR, Paulson D, Prihoda TJ, Otto RA.

Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):36-8.

PMID:
16415427
43.

Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.

Daniel KG, Chen D, Orlu S, Cui QC, Miller FR, Dou QP.

Breast Cancer Res. 2005;7(6):R897-908. Epub 2005 Sep 20.

44.
45.

Positron emission tomography in the management of unknown primary head and neck carcinoma.

Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA.

Arch Otolaryngol Head Neck Surg. 2005 Jul;131(7):626-9.

PMID:
16027287
46.

Protein pI shifts due to posttranslational modifications in the separation and characterization of proteins.

Zhu K, Zhao J, Lubman DM, Miller FR, Barder TJ.

Anal Chem. 2005 May 1;77(9):2745-55.

PMID:
15859589
47.

Structure-activity relationships OF N-methylthiolated beta-lactam antibiotics with C3 substitutions and their selective induction of apoptosis in human cancer cells.

Kuhn DJ, Wang Y, Minic V, Coates C, Reddy GS, Daniel KG, Shim JY, Chen D, Landis-Piwowar KR, Miller FR, Turos E, Dou QP.

Front Biosci. 2005 May 1;10:1183-90.

PMID:
15769617
48.
49.

Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.

Mehta K, Fok J, Miller FR, Koul D, Sahin AA.

Clin Cancer Res. 2004 Dec 1;10(23):8068-76.

50.

Use of two-dimensional liquid fractionation for separation of proteins from cell lysates without the presence of methionine oxidation.

Zhua K, Kachman MT, Miller FR, Lubman DM, Zand R.

J Chromatogr A. 2004 Oct 22;1053(1-2):133-42.

PMID:
15543979

Supplemental Content

Loading ...
Support Center